PE/Cyanine7 anti-human CD69 Antibody
- 产品名称：
- PE/Cyanine7 anti-human CD69 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 310911
- 产品应用：
- 310911
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1716 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Chimpanzee, Cynomolgus, Pigtailed Macaque, Rhesus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections2, immunofluorescence microscopy3, and spatial biology (IBEX)8,9.
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Knapp WB, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
- Sakkas LI, et al. 1998. Clin. and Diag. Lab. Immunol. 5:430. (IHC)
- Kim JR, et al. 2005. BMC Immunol. 6:3. (IF)
- Verjans GM, et al. 2007. P. Natl. Acad. Sci. USA 104:3496.
- Lu H, et al. 2009. Toxicol Sci. 112:363. (FC) PubMed
- Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
- Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
- Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
- Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
- Product Citations
-
- Balachandran H, et al. 2022. Cell Rep. 38:110345. PubMed
- Hall J, et al. 2014. Brain Behav Immun. 36:156. PubMed
- Wang H, et al. 2022. Front Immunol. 13:852436. PubMed
- Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed
- Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
- Knippenberg S, et al. 2011. J Neuroimmunol. 28:239. PubMed
- Ophir M, et al. 2013. J Cell Biol. 203:1021. PubMed
- Presicce P, et al. 2011. PLoS One. 6:e28118. PubMed
- Maritz MF, et al. 2018. PLoS One. 13:e0196043. PubMed
- Gullà A, et al. 2021. Cancer Discov. . PubMed
- Jürchott K, et al. 2016. PLoS One. 11: 0150812. PubMed
- Smolders J, et al. 2010. PLoS One. 5:e15235. PubMed
- Ray RM, et al. 2019. Sci Rep. 9:4334. PubMed
- Mudd PA, et al. 2022. Cell. 185:603. PubMed
- Valestrand L, et al. 2022. Am J Pathol. . PubMed
- Vadrevu KM, et al. 2022. Sci Rep. 12:12038. PubMed
- Horwitz JA, et al. 2017. Cell. 170:637. PubMed
- Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
- Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
- Phadnis-Moghe A, et al. 2015. Toxicol Sci. 144:39. PubMed
- Pham TNQ, et al. 2020. Cell Reports. 29(9):2770-2782.e5.. PubMed
- Inui M, et al. 2015. Int Immunol. 27: 345 - 355. PubMed
- Gullà A, et al. 2021. Cancer Discov. 2:468. PubMed
- Csomós K, et al. 2022. Nat Immunol. 23:1256. PubMed
- Ormonde JVS, et al. 2018. J Immunol. 201:3431. PubMed
- Assen S, et al. 2011. Clin Immunol. 141:161. PubMed
- Lu H, et al. 2009. Toxicol Sci. 112:363. PubMed
- Ribot J, et al. 2014. J Immunol. 192:2237. PubMed
- RRID
- AB_314846 (BioLegend Cat. No. 310911) AB_314847 (BioLegend Cat. No. 310912)
- Structure
- C-type lectin, type II glycoprotein, 28/32 kD
- Distribution
-
Activated T cells, B cells, NK cells, granulocytes, thymocytes, platelets, Langerhans cells
- Function
- Lymphocyte, monocyte, and platelet activation, NK cell killing
- Cell Type
- B cells, Granulocytes, Langerhans cells, NK cells, Platelets, T cells, Thymocytes, Tregs
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. Testi R, et al. 1994. Immunol. Today 15:479.
- Gene ID
- 969 View all products for this Gene ID
- UniProt
- View information about CD69 on UniProt.org
